Tg Therapeutics reported $3.02M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US $ 328M 33M
Ardelyx ARDX:US $ 0.79M 0.04M
Biogen BIIB:US $ 65.8M 0.3M
Dynavax Technologies DVAX:US $ 1.68M 0M
Gilead Sciences GILD:US $ 242M 4M
Infinity Pharmaceuticals INFI:US $ 0.04M 0M
Intercept Pharmaceuticals ICPT:US $ 6.67M 0M
Karyopharm Therapeutics KPTI:US $ 6.31M 371K
Novartis NOVN:VX 202M 1000K
Ptc Therapeutics PTCT:US $ 22.28M 1.34M
Puma Biotechnology PBYI:US $ 2.7M 0.04M
Regeneron Pharmaceuticals REGN:US $ 13.1M 0.5M
Tg Therapeutics TGTX:US $ 3.02M 0.35M
Verastem VSTM:US $ 0.64M 0.58M
Vertex Pharmaceuticals VRTX:US $ 14.6M 0.3M
Ziopharm Oncology ZIOP:US 740K 57K